Results 81 to 90 of about 305,149 (190)

Long-term prognosis in patients with thymoma combined with myasthenia gravis: a propensity score-matching analysis

open access: yesFrontiers in Medicine
IntroductionWe aimed to assess the impact of myasthenia gravis (MG) on the long-term prognosis in patients with thymoma after surgery and identify related prognostic factors or predictors.MethodsThis retrospective observational study included 509 ...
Kai Zhao   +11 more
doaj   +1 more source

Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report

open access: yesBMC Neurology, 2019
Background Autoimmune encephalitis (AE) is a newly recognized autoimmune disorders in which the targets are proteins or receptors involved in synaptic transmission and neuronal excitability.
Qingyang Luo, Xianghong Wu, Wen Huang
doaj   +1 more source

Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long‐Term Real‐World Study

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
This prospective cohort study identifies independent predictors of relapse following complete treatment discontinuation in 196 myasthenia gravis (MG) patients who achieved minimal symptom expression (MSE). Cox regression analysis revealed late‐onset MG (age ≥ 50 years) as a risk factor, while rituximab therapy, longer treatment duration, and extended ...
Dingxian He   +7 more
wiley   +1 more source

Risk of New‐Onset Myasthenia Gravis Following COVID‐19 Infection and Vaccination: A Population‐Based Case–Control Study

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
This population‐based case–control study using the Clalit Health Services database (Israel) evaluated adults ≥ 18 years (2020–2022) to assess the risk of new‐onset myasthenia gravis (MG) following confirmed SARS‐CoV‐2 infection or Pfizer‐BioNTech (BNT162b2) vaccination.
Tasneem Kab   +6 more
wiley   +1 more source

Thymoma with Autoimmune Hemolytic Anemia

open access: yesCase Reports in Oncology, 2014
A 38-year-old Japanese male was referred to our hospital with abnormal chest X-ray results and severe Coombs-positive hemolytic anemia. He was diagnosed with a stage IV, WHO type A thymoma and was treated with oral prednisolone (1 mg/kg/day) and ...
Kensuke Suzuki   +4 more
doaj   +1 more source

B cell deficiency in thymoma tissues of Good’s syndrome patients

open access: yesDiscover Oncology
Objectives Good’s syndrome (GS) is a rare secondary immunodeficiency which is characterized by hypogammaglobulinemia and thymoma. This study aims to investigate the expression and distribution of B cells in thymoma tissue, given that B cells had been ...
Junwu Zhang   +4 more
doaj   +1 more source

Good’s syndrome revealed by recurrent sigmoid diverticulitis

open access: yesEuropean Journal of Case Reports in Internal Medicine
Thymus is a primary lymphoid organ whose main function is the education of the T lymphocytes. Thymoma is uncommon neoplasia derived from epithelial cells of the thymus. Patients with thymoma frequently present with autoimmune disorders, mostly myasthenia
Hassene Attout   +4 more
doaj   +1 more source

Thymoma [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1932
openaire   +2 more sources

Giant thymoma [PDF]

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2003
Sandeep, Agarwala   +2 more
openaire   +2 more sources

[Thymomas].

open access: yesAnales de medicina interna (Madrid, Spain : 1984), 1991
Thymomas are non-frequent neoplasias which are interesting because of their special association with the immune system pathology; although the pathogenic relationship has yet to be confirmed. A literature review is carried out on clinical aspects, prognosis and treatment, basically chemotherapy in advanced cases.
A B, Sánchez Heras   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy